PTC Therapeutics Inc (PTCT)
25.16
-0.10
(-0.40%)
USD |
NASDAQ |
Apr 17, 16:00
25.16
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Gross Profit Margin (Quarterly): 90.52% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 90.52% |
| September 30, 2023 | 95.17% |
| June 30, 2023 | 94.05% |
| March 31, 2023 | 93.58% |
| December 31, 2022 | 93.49% |
| September 30, 2022 | 93.55% |
| June 30, 2022 | 94.18% |
| March 31, 2022 | 93.19% |
| December 31, 2021 | 94.36% |
| September 30, 2021 | 95.29% |
| June 30, 2021 | 93.69% |
| March 31, 2021 | 92.28% |
| December 31, 2020 | 95.89% |
| September 30, 2020 | 96.06% |
| Date | Value |
|---|---|
| June 30, 2020 | 92.95% |
| March 31, 2020 | 94.02% |
| December 31, 2019 | 96.33% |
| September 30, 2019 | 95.79% |
| June 30, 2019 | 96.25% |
| March 31, 2019 | 95.57% |
| December 31, 2018 | 95.64% |
| September 30, 2018 | 93.86% |
| June 30, 2018 | 96.26% |
| March 31, 2018 | 94.57% |
| December 31, 2017 | 96.88% |
| September 30, 2017 | 96.22% |
| June 30, 2017 | 98.42% |
| March 31, 2017 | 99.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
90.52%
Minimum
Dec 2023
96.33%
Maximum
Dec 2019
94.24%
Average
94.05%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 88.87% |
| Catalyst Pharmaceuticals Inc | 85.70% |
| Pfizer Inc | 46.92% |
| Geron Corp | -- |
| Perspective Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -40.12% |
| Return on Invested Capital | -137.9% |
| Profit Margin (Quarterly) | -50.74% |
| Operating Margin (Quarterly) | 1.02% |
| Return on Net Operating Assets | -63.20% |